Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 15, 2021

SELL
$8.98 - $11.6 $898 - $1,160
-100 Closed
0 $0
Q4 2018

Jan 30, 2019

SELL
$20.07 - $46.7 $2,007 - $4,670
-100 Reduced 50.0%
100 $2,000
Q1 2018

May 18, 2018

BUY
$59.7 - $99.25 $5,970 - $9,925
100 Added 100.0%
200 $14,000
Q4 2017

Feb 02, 2018

BUY
$93.85 - $132.45 $9,385 - $13,244
100
100 $10,000

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $154M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Trust CO Of Vermont Portfolio

Follow Trust CO Of Vermont and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.